Showing results (551-560 of 586) with videos related to
Sort By:
Pageof 59
Plos Pathogens|July 3, 2007
Characterization of reemerging chikungunya virusMarion Sourisseau, Clémentine Schilte, Nicoletta Casartelli, et al.Nature Immunology|May 5, 2018
Publisher Correction: Natural variation in the parameters of innate immune cells is preferentially driven by genetic factorsEtienne Patin, Milena Hasan, Jacob Bergstedt, et al.Life (Basel, Switzerland)|June 2, 2021
Impact of TSPO Receptor Polymorphism on [<sup>18</sup>F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative DisordersFranziska J Vettermann, Stefanie Harris, Julia Schmitt, et al.Clinical and Translational Radiation Oncology|May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.Nature Immunology|February 25, 2018
Natural variation in the parameters of innate immune cells is preferentially driven by genetic factorsEtienne Patin, Milena Hasan, Jacob Bergstedt, et al.Nature Cell Biology|August 29, 2017
Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiencyEvangelos Giampazolias, Barbara Zunino, Sandeep Dhayade, et al.Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.Journal of Neuroinflammation|February 24, 2023
Depletion and activation of microglia impact metabolic connectivity of the mouse brainJohannes Gnörich, Anika Reifschneider, Karin Wind, et al.Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.Pageof 59